ReviewTrials2013
Confronting diversity in the production of clinical evidence goes beyond merely including under-represented groups in clinical trials.
Review in Trials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Experiences of participant burden in an Alzheimer's disease research center longitudinal cohort.Journal of Alzheimer's disease : JAD · 2026Article
- Improving Representation of Underserved Populations in Cardiovascular Research.Journal of the American Heart Association · 2025Review
- Exploring the implicit meanings of 'cultural diversity': a critical conceptual analysis of commonly used approaches in medical education.Advances in health sciences education : theory and practice · 2025Review
- Participation of under-represented communities in an online cognitive ageing platform and predictors of willingness to be contacted for future research.BMJ public health · 2025Article
- Racial and ethnic diversity in global neuroscience clinical trials.Contemporary clinical trials communications · 2024Article
- Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System.JAMA network open · 2022Article
- Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response.British journal of clinical pharmacology · 2022Review
- Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer.Journal of the National Cancer Institute · 2022Article
- Derivation of a natural language processing algorithm to identify febrile infants.Journal of hospital medicine · 2022Article
- Optimizing a digital intervention for managing blood pressure in stroke patients using a diverse sample: Integrating the person-based approach and patient and public involvement.Health expectations : an international journal of public participation in health care and health policy · 2021Article
- Enhancing diversity to reduce health information disparities and build an evidence base for genomic medicine.Personalized medicine · 2018Article
- Beyond sex and gender difference in funding and reporting of health research.Research integrity and peer review · 2018Article
- How should we evaluate research on counselling and the treatment of depression? A case study on how the National Institute for Health and Care Excellence's draft 2018 guideline for depression considered what counts as best evidence.Counselling and psychotherapy research · 2017Article
- Searching for sex- and gender-sensitive tuberculosis research in public health: finding a needle in a haystack.International journal of women's health · 2016Article
- Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden.European journal of public health · 2015Article
- Considerations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samples.Analytical and bioanalytical chemistry · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is increasing evidence that outcomes of health care differ by patient characteristics, such as gender and ethnicity. If evidence-based medicine is to improve quality of care for all patients, it is essential to take this diversity into account when designing clinical studies. So far, this notion has mainly been translated into recommendations for including minority populations in trials. We argue that a more comprehensive view of the production of diversity-sensitive clinical evidence is needed, one that takes heterogeneity as a starting point in research. We call for a mix of methodological approaches aimed at identifying diversity issues that matter and analysing the impact of these diversities on clinical outcomes. Institutional changes are necessary to support this methodological reform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.